AI assistant
Glenmark Pharmaceuticals ltd — Capital/Financing Update 2024
Mar 6, 2024
62608_rns_2024-03-06_869b2de1-9fb1-4207-b039-6396bd1befa3.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [34 x 32] intentionally omitted <==
==> picture [148 x 45] intentionally omitted <==
March 6, 2024
To, Dy. General Manager Department of Corporate Services, BSE Ltd. Phiroze Jeejeebhoy Towers Dalal Street, Fort, Mumbai – 400 001 Ref: Scrip Code: 532296
To, The Manager – Listing National Stock Exchange of India Ltd., Plot No. C/1, G Block, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051 Ref: Scrip Name: GLENMARK
Dear Sir/Madam,
Sub: Disclosure pursuant to Regulation 30(7) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
We refer to our letter dated September 21, 2023 in relation to the sale of 91,895,379 equity shares (“ Sale Shares ”) representing 75.00% of the issued and paid-up equity share capital of Glenmark Life Sciences Limited (“ GLS ”), a subsidiary of the Company, to Nirma Limited (the “ Buyer ) in accordance with the terms of the share purchase agreement dated September 21, 2023 among the Company, GLS and the Buyer (the “ Share Purchase Agreement ”).
Closing under the Share Purchase Agreement has been initiated; 67,389,944 equity shares representing 55% of the issued and paid-up equity share capital of GLS have been transferred by the Company to the Buyer; and closing will be complete upon the completion of the transfer of the remaining Sale Shares.
This is for your information and records. Request you to please ignore the earlier letter.
Yours faithfully,
For Glenmark Pharmaceuticals Limited
HARISH Digitally signed by HARISH VINAYAK VINAYAK KUBER Date: 2024.03.06 KUBER 17:11:14 +05'30'
Harish Kuber Company Secretary & Compliance Officer
Glenmark Pharmaceuticals Ltd. Glenmark House, B D Sawant Marg, Andheri (E), Mumbai 400 099, India T: 91 22 4018 9999 F: 91 22 4018 9988 CIN No: L24299MH1977PLC019982 W: www.glenmarkpharma.com Registered office: B/2, Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai 400 026 E: [email protected]